StonvexLoading…
StonvexStonvexStonvexCore line items from ALKS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.48B | $1.56B | $1.66B | $1.11B |
Operating Income | $253.96M | $420.64M | $414.12M | $-6.09M |
Net Income | $241.66M | $367.07M | $355.76M | $-158.27M |
EPS (Diluted) | $1.43 | $2.17 | $2.10 | $-0.97 |
Total Assets | $2.49B | $2.06B | $2.14B | $1.96B |
Total Liabilities | $667.70M | $590.59M | $933.54M | $920.23M |
Cash & Equivalents | $388.57M | $291.15M | $457.47M | $292.47M |
Free Cash Flow OCF − CapEx | $480.33M | $405.64M | $353.31M | $-17.21M |
Shares Outstanding | 165.61M | 162.18M | 166.98M | 164.38M |